Targeted Delivery of Kinase Inhibitors: A Nanomedicine Approach for Improved Selectivity in Cancer

E-ISSN： 2212-389x|6|2|267-278

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.6, Iss.2, 2011-05, pp. : 267-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Renal Delivery of Protein Kinase Inhibitors for the Treatment of Chronic Kidney Disease

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 249-259

Bentham Science Publishers

Access to resources Recommend Favorite

HER-Targeted Tyrosine-Kinase Inhibitors

Oncology, Vol. 63, Iss. 1, 2002-11 ,pp. : 6-16

Karger

Access to resources Recommend Favorite

Safety of Multi-Targeted Kinase Inhibitors as Monotherapy Treatment of Cancer: A Systematic Review of the Literature

Current Drug Safety, Vol. 4, Iss. 2, 2009-05 ,pp. : 143-154

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery, detection and development in nanomedicine

By Vetro Joseph A

Nanomedicine, Vol. 1, Iss. 4, 2006-12 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite

Efficacy of phosphatidylinositol‐3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2234-2242

John Wiley & Sons Inc

Access to resources Recommend Favorite